News archives


JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  4th July 2012  
  Wip1-dependent regulation of autophagy, obesity and atherosclerosis.
 
 




Authors
Xavier Le Guezennec1, Anna Brichkina1, Yi-Fu Huang1, Elena Kostromina2, Weiping Han2, Dmitry V Bulavin1

1 - Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673.
2 - Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium, Biomedical Sciences Institutes,      11 Biopolis Way, Helios, Singapore 138667.

Published in Cell Metabolism on 3rd July 2012. ( Please click here for article. )

Please click here for Press Release

Abstract
Obesity and atherosclerosis-related diseases account for over one-third of deaths in the Western world. Controlling these conditions remains a major challenge due to an incomplete understanding of the molecular pathways involved. Here, we show that Wip1 phosphatase, a known negative regulator of ATM-dependent signaling, plays a major role in controlling fat accumulation and atherosclerosis in mice; specifically, Wip1 deficiency prevents both conditions. In the course of atherosclerosis, deletion of Wip1 results in suppression of macrophage conversion into foam cells, thus preventing the formation of atherosclerotic plaques. This process appears to be independent of p53 but rely on a non-canonical ATM-mTOR signaling pathway and on selective autophagy in regulation of cholesterol efflux. We propose that the Wip1-dependent control of autophagy and cholesterol efflux may provide new avenues for treating obesity and atherosclerosis.


Figure Legend:
Wip1 deficiency prevents Atherosclerosis in ApoE-/- background
Gross view of aortas stained with Sudan red from apoE-/- and apoE-/- Wip1-/- mice.

For more information on Dmitry BULAVIN's laboratory, please click here.